Eliminating extravasation events: a multidisciplinary approach.
J Infus Nurs
; 37(3): 157-64, 2014.
Article
em En
| MEDLINE
| ID: mdl-24694509
ABSTRACT
Administration of chemotherapy agents can give rise to many safety issues. Extravasation of a vesicant agent causes tissue blistering and necrosis. This complication of chemotherapy administration causes additional pain and suffering in patients who are already suffering with a diagnosis of cancer. Nurses hold key responsibilities for educating patients about administration issues and following practice standards to minimize the risk of extravasation. Defining a path of shared responsibilities among team members is a critical step in assuring the safe administration of drugs classified as vesicants. This article describes a clinical practice change that is used at a large midwestern academic medical cancer center. This practice and policy change has resulted in a 90% reduction in the administration of vesicant agents peripherally, with no occurrence of extravasations in the first 6 months of implementation.
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Extravasamento de Materiais Terapêuticos e Diagnósticos
/
Antineoplásicos
Tipo de estudo:
Etiology_studies
/
Guideline
Limite:
Humans
Idioma:
En
Revista:
J Infus Nurs
Assunto da revista:
ENFERMAGEM
Ano de publicação:
2014
Tipo de documento:
Article